Home / Street Sector / Recommended Mix Momentum Stocks: Williams Partners (NYSE:WPZ), Cynapsus Therapeutics (CYNA), Broadcom (AVGO)

Recommended Mix Momentum Stocks: Williams Partners (NYSE:WPZ), Cynapsus Therapeutics (CYNA), Broadcom (AVGO)

Williams Partners L.P. (NYSE:WPZ) [Trend Analysis] try to make new thrust in street and making different trends, stocks trading ended with 0.15% to $37.92. Williams Partners L.P. (WPZ) released that Transcontinental Gas Pipe Line Firm, LLC (Transco) has filed an application with the Federal Energy Regulatory Commission (FERC) looking for authorization to construct a 475,000 dekatherm per day (Dth/d) expansion in Texas and Louisiana to connect U.S. natural gas supplies with global liquefied natural gas (LNG) markets.

Constructed in two phases, the Gulf Connector Project is deinked to deliver 75,000 Dth/d to Freeport LNG Development, L.P.’s liquefaction project by the second half of 2018, and 400,000 Dth/d to Cheniere Energy’s Corpus Christi liquefaction terminal in 2019. Pending appropriate regulatory authorization s, construction on the first phase of the project will start in the third quarter of 2017 in order to be placed into service during the second half of 2018. The share price of WPZ attracts active investors, as stock price of week volatility recorded 1.69%. The stock is going forward to its 52-week low with 215.41% and lagging behind from its 52-week high price with -1.07%.

Cynapsus Therapeutics Inc. (NASDAQ:CYNA) [Trend Analysis] plunged reacts as active mover, shares a loss -0.01% to traded at $39.69 and the percentage gap among open changing to regular change was 0.00%. Sunovion Pharmaceuticals Inc. reported that it has agreed to buy Cynapsus Therapeuticals Inc. (CYNA) for $40.50 a share in an all-cash accord that values the Toronto-based Cynapsus at $624 million and represents a 120% premium over Cynapsus’ close of $18.36 on Wednesday. Both companies’ bodhave agreed the acquisition, predictable to close this fall, the companies stated in a statement. Cynapsus is testing medication to treat Parkinson’s disease and “pivotal” clinical trials are underway, the firm stated on its website.

Broadcom Limited (NASDAQ:AVGO) [Trend Analysis] attempts to attain leading position in street, Shares price changes as it -2.22% to close at $173.15 with the total traded volume of 4.8 Million shares. The firm has institutional ownership of 93.30%, while insider ownership included 0.20%. Its price to sales ratio ended at 7.83. AVGO attains analyst recommendation of 1.70 with week performance of 0.60%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Check Also

Recommended Momentum ‘How’ and ‘Why’: PPG Industries (NYSE:PPG), Allergan (NYSE:AGN)

PPG Industries, Inc. (NYSE:PPG) [Trend Analysis] try to make new thrust in street and making different …

Leave a Reply

Your email address will not be published. Required fields are marked *